A novel mutation in the antithrombin gene (insT 7429-30) causes superior mesenteric vein thrombosis

Thrombosis Research

Volumn 119, Issue 6, 2007, Pages 793-796

  Bagnobianchi, A ^a   Ordonez A ^a   Minano A ^a   Sanchez I ^a   Cano, H ^a   del Rey, Maria L ^a   Hernandez Espinosa D ^a   Gonzalez Conejero R ^a   Corral, J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTITHROMBIN;

ABDOMINAL PAIN; ADULT; ANTITHROMBIN DEFICIENCY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; EXON; GENE MUTATION; HUMAN; HYPERCHOLESTEROLEMIA; LAPAROTOMY; LETTER; MALE; MESENTERIC VEIN THROMBOSIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

ANTITHROMBINS; HUMANS; INTRONS; MALE; MESENTERIC VEINS; MIDDLE AGED; MUTATION; PEDIGREE; THYMINE; VENOUS THROMBOSIS;

EID: 33947305785     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.06.004     Document Type: Letter

References (13)

1. Eliot J.W. The operative relief of gangrene of the intestine due to occlusion of the mesenteric vessels. Ann Surg 21 (1895) 9-23
2. Kumar S., Sarr M.G., and Kamath P.S. Current concepts: mesenteric venous thrombosis. N Engl J Med 345 (2001) 1683-1688
3. Ishiguro K., Kojima T., Kadomatsu K., Nakayama Y., Takagi A., Suzuki M., et al. Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest 106 (2000) 873-878
4. Pabinger I., and Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose-und Hamostaseforschung (GTH) Study Group on Natural Inhibitors. Arterioscler Thromb Vasc Biol 16 (1996) 742-748
5. Wilson C., Walker I.D., Davidson J.F., and Imrie C.W. Mesenteric venous thrombosis and antithrombin III deficiency. J Clin Pathol 40 (1987) 906-908
6. Joh J.H., and Kim D.I. Mesenteric and portal vein thrombosis: treated with early initiation of anticoagulation. Eur J Vasc Endovasc Surg 29 (2005) 204-208
7. Gruenberg J.C., Smallridge R.C., and Rosenberg R.D. Inherited antithrombin-III deficiency causing mesenteric venous infarction: a new clinical entity. Ann Surg 181 (1975) 791-794
8. Bickelhaupt A., Jehle M., and Eisele R. Thrombolytic therapy of antithrombin III-deficiency-induced mesenteric vein thrombosis in a newly operated patient. Vasa 20 (1991) 78-81
9. Grewal H.P., and Barrie W.W. Congenital antithrombin III deficiency causing mesenteric venous infarction: a lesson to remember-a case history. Angiology 43 (1992) 618-620
10. Takenaga M., Horinouchi K., Shirieda K., Fukudome T., and Fujimoto T. A novel nonsense mutation in the antithrombin III gene (Ser365 to stop) causing deep and mesenteric venous thromboses. Thromb Haemost 85 (2001) 570-571
11. Muta T., Okamura T., Kawamoto M., Ichimiya H., Yamanaka M., Wada Y., et al. Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency. Eur J Haematol 75 (2005) 167-170
12. Corral J., Gonzalez-Conejero R., Soria J.M., Gonzalez-Porras J.R., Perez-Ceballos E., Lecumberri R., et al. A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis. Blood (Mar 9 2006) [Electronic publication ahead of print]
13. Bayston T.A., and Lane D.A. Antithrombin: molecular basis of deficiency. Thromb Haemost 78 (1997) 339-343